Metabolism of dynorphin A1-13 in human CSF

Neurochemical Research

Volumn 21, Issue 10, 1996, Pages 1213-1219

  Müller, Stefan ^a   Grundy, Betty L ^b   Hochhaus, Günther ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

CSF; Dynorphin; metabolism; opioid peptides

Indexed keywords

CAPTOPRIL; CARBOXYPEPTIDASE; DYNORPHIN[1-13]; DYNORPHIN[1-6]; DYNORPHIN[3-13];

ADULT; AGED; AGING; ARTICLE; CEREBROSPINAL FLUID; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN METABOLISM;

ADULT; AGED; AGING; AMINOPEPTIDASES; CARBOXYPEPTIDASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DYNORPHINS; ENZYME INHIBITORS; FEMALE; HALF-LIFE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PEPTIDE FRAGMENTS;

EID: 0029859560     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532398     Document Type: Article

References (22)

1. Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapillar, M., and Hood, L. 1979. Dynorphin-(1-13), an extraordinarily potent opiod peptide. Proc. Natl. Acad. Sci. USA, 76:6666-6670.
2. Herman, B. H., and Goldstein, A. 1985. Antinociception and paralysis induced by intrathecal dynorphin A. J. Pharm. Exp. Ther., 232:27-32.
3. Wen, H. L., and Ho, W. K. K. 1982. Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur. J. Pharmacol., 82:183-186.
4. Mueller, S., and Hochhaus, G. 1995. Metabolism of dynorphin A1-13 in human blood and plasma. Pharm. Res., 12:1165-1170.
5. Leslie, F. M., and Goldstein, A. 1982. Degradation of dynorphin A1-13 by membrane-bound rat brain enzymes. Neuropeptides, 2:185-196.
6. Terenius, L., and Nyberg, F. 1988. Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid. Int. Rev. Neurobiology, 30:101-121.
7. Nyberg, F., Nordstrom, K., and Terenius, L. 1985. Endopeptidase in human cerebrospinal fluid which cleaves proenkephalin B opioid peptides at consecutive basic amino acids. Biochem. Biophys. Res. Com., 131:1069-1074.
8. Persson, S., Post, C., Alari, L., Nyberg, F., and Terenius, L. 1989. Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats. Neurosc. Lett., 107:318-322.
9. Hazato, T., Shimamura, M., Katayama, T., Kasama, A., Nishioka, S., and Kaya, K. 1983. Enkephalin degrading enzymes in cerebrospinal fluid. Life Sciences, 33:443-448.
10. S. Bolton, 1990, Pharmaceutical Statistics, Dekker, New York and Basel, p. 250.
11. Seyfried, C. A., and Tobler, P. 1990. HPLC systems for the separation of dynorphin A (1-17) fragments and its application in enzymolysis studies with rat nerve terminal membranes. J. Chrom., 529:43-54.
12. Shibanoki, S., Weinberger, S. B., Ishikawa, K., and Martinez, J. L. 1991. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations. Regul-Pept., 32:267-278.
13. Gideon, P., Thomsen, C., Ståhlberg, F., and Henriksen, O. 1994. Cerebrospinal fluid production and dynamics in normal aging: a MRI phase-mapping study. Acta Neurol. Scand. 89:362-366.
14. A. J. Kenny and N. M. Hooper 1991. Peptidases involved in the metabolism of bioactive peptides. Pages 47-79. In J. H. Hendriksen (ed.), Degradation of bioactive substances: Physiology and pathophysiology, CRC Press, Inc., Boca Raton.
15. Lantz, I., Nyberg, F., and Terenius, L. 1991. Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid. Biochem. Int., 23:941-948.
16. Nyberg, F., Lyrenas, S., and Terenius, L. 1986. Assay and biochemical characterization of a dynorphin converting enzyme in human cerebrospinal fluid. NIDA Res. Monogr., 75:251-254.
17. Yukhananov, R. Y., Zhai, Q. Z., Persson, S., Post, C., and Nyberg, F. 1993. Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens. Neuropharmacology, 32:703-709.
18. Takemori, A. E., Loh, H. H., and Lee, N. N. 1993. Suppression by dynorphin A and [des-Tyr1] dynorphin A peptides of the ex-pression of opiate withdrawal and tolerance in morphine-dependent mice. J. Pharm. Exp. Ther., 266:121-124
19. Shukla, V. K., and Lemaire, S. 1994. Non-opioid effects of dynorphins: possible role of the NMDA-receptor., TIPS, 15:420-424
20. Persson, S., Le Greves, M., Thörnwall, M., Eriksson, U., Silberring, J., and Nyberg, F. 1995. Neuropeptide converting, and processing enzymes in the spinal cord and cerebrospinal fluid. Pages 111-130 in Nyberg, F., Sharma, H. S., Wiesenfeld-Hallin, Z. (eds), Progress in brain research, Vol 104, Elsevier Science, Amsterdam.
21. Csuhai, E., Little, S. S., and Hersh, L. B. 1995. Inactiviation of neuropeptides. Pages 131-142, in Nyberg, F., Sharma, H. S., Wiesenfeld-Hallin, Z. (eds), Progress in brain research, Vol 104, Elsevier Science, Amsterdam.
22. Benter, I. F., Hirsh, E. M., Tuchman, A. J., Ward, P. E. 1990. N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid. Biochem. Pharmacol. 40:465-472.